no worries. I've done further reading and it appears to me Edwards is driving two product lines, the Sapien models and the Resilia models. Sapien X4 clinical development this year, Resilia Inspiris/Konect already approved and being promoted as a premium models? Edwards spends $US200m a quarter on R&D! Medtronic looking to release Evolut FX later this year. A lot of working going into making better models which reduce or eliminate paravulvar leakage which appears to be a common problem with these types of valves.
I found this PDF which lists next generation TAVR devices. The Boston Scientific valve is obviously no longer available.
https://www.nytranscathetervalves.org/wp-content/uploads/2020/12/Abizaid-Current-Update-on-Next-Generation.pdf
- Forums
- ASX - By Stock
- AVR
- Ann: Anti-Calcification Study
Ann: Anti-Calcification Study, page-71
-
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.30 |
Change
-0.380(2.42%) |
Mkt cap ! $323.4M |
Open | High | Low | Value | Volume |
$15.70 | $15.94 | $15.02 | $290.0K | 18.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 280 | $15.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.57 | 779 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 280 | 15.100 |
2 | 96 | 15.020 |
1 | 15 | 15.010 |
2 | 582 | 15.000 |
1 | 1000 | 14.850 |
Price($) | Vol. | No. |
---|---|---|
15.570 | 779 | 1 |
15.930 | 250 | 1 |
15.940 | 554 | 1 |
15.950 | 848 | 2 |
16.000 | 1250 | 2 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |